Path | β(95% CI) |  | |||
---|---|---|---|---|---|
PSYIPV → CMD | 0.112 (0.030 - 0.194) | ** | |||
PHYIPV → CMD | 0.227 (0.134 - 0.321) | *** | |||
STRESS → CMD | 1.145 (0.877 - 1.413) | *** | |||
F SEP → CMD | −0.982 (−1.294 - –0.669) | *** | |||
PSYIPV → PHYIPV | 0.440 (0.386 - 0.494) | *** | |||
ALC → PHYIPV | 0.129 (0.067 - 0.192) | * | |||
DRUGS → PHYIPV | 1.239 (1.095 - 1.384) | ** | |||
ALC → PSYIPV | 0.143 (0.022 - 0.263) | *** | |||
DRUGS → PSYIPV | 0.667 (0.271 - 1.062) | *** | |||
STRESS → PSYIPV | 0.557 (0.297 - 0.817) | *** | |||
INSTAB → PSYIPV | 1.090 (0.719 - 1.462) | *** | |||
UNDR5 → PSYIPV | 0.429 (0.127 - 0.730) | *** | |||
STRESS → ALC | 0.379 (0.222 - 0.536) | *** | |||
INSTAB → ALC | 0.676 (0.476 - 0.876) | *** | |||
UNDR5 → ALC | −0.355 (−0.557 - –0.154) | *** | |||
F SEP → ALC | −0.496 (−0.733 - –0.258) | *** | |||
STRESS → DRUGS | 0.059 (0.009 - 0.108) | * | |||
AGE → DRUGS | −0.010 (−0.018 - –0.003) | ** | |||
INSTAB → DRUGS | 0.183 (0.127 - 0.240) | *** | |||
UNDR5 → DRUGS | −0.094 (−0.162 - –0.025) | ** | |||
F SEP → DRUGS | −0.160 (−0.232 - –0.088) | *** | |||
F SEP → STRESS | −0.188 (−0.263 - –0.114) | *** | |||
F SEP → AGE | 0.915 (0.380 - 1.449) | ** | |||
AGE → INSTAB | −0.041 (−0.056 - –0.026) | *** | |||
F SEP → INSTAB | −0.312 (−0.443 - –0.182) | *** | |||
F SEP → UNDR5 | −0.455 (−0.591 - –0.319) | *** | |||
BCEC → F SEP †| 0.512 (0.434 - 0.591) | *** | |||
HOUSE → F SEP †| 0.694 (0.624 - 0.764) | *** | |||
EDUC → F SEP †| 0.582 (0.506 - 0.657) | *** | |||
Model Adjustment | Â | Â | Â | Â | |
RMSEA | 0.042 | (90% CI: 0.031 - 0.053); p ≤ .05 = 0.883 |  | ||
CFI | 0.967 | Â | Â | Â | Â |
TLI | 0.942 | Â | Â | Â | Â |